6 ms·
The FDA already takes that into account when doing a risk/benefit assessment. If you're looking to treat relatively health people for most of their lives (say
by refurb 7y ago
The FDA already takes that into account when doing a risk/benefit assessment.
If you're looking to treat relatively health people for most of their lives (say a drug that precent type I diabetes), the FDA will scrutinize the hell out of it.
If you're looking to treat someone who is dying (e.g. metastatic cancer), then the FDA is much more lenient in their analysis.